Whitebox Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Whitebox Advisors’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-15,078	Closed	-$94K	–	374
2015 Q3	$94K	Sell	15,078 -145,740	-91%	-$1.36M	﹤0.01%	325
2015 Q2	$1.6M	Buy	+160,818	New	+$1.41M	0.07%	222
2014 Q4	–	Sell	-20,000	Closed	-$101K	–	477
2014 Q3	$101K	Buy	+20,000	New	+$123K	﹤0.01%	384
2014 Q1	–	Sell	-548,367	Closed	-$2.07M	–	493
2013 Q4	$2.07M	Buy	548,367 +266,677	+95%	+$1.03M	0.09%	169
2013 Q3	$946K	Sell	281,690 -478,725	-63%	-$1.67M	0.05%	254
2013 Q2	$2.54M	Buy	+760,415	New	+$2.76M	0.13%	87

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Whitebox Advisors's NWBO Position: Q4 2015 in Review

Whitebox Advisors sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2015, closing a stake of 15,078 shares — an estimated $94K sold.

Whitebox Advisors first reported a position in NWBO in Q2 2013 and held it in 6 quarters. The position peaked at $2.54M in Q2 2013. 80 funds tracked by Wall St. Rank hold NWBO as of Q4 2015.

Whitebox Advisors reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2015 after selling out during the quarter.
Whitebox Advisors sold 15,078 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2015, an estimated $94K.
Whitebox Advisors first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 6 quarters.
Whitebox Advisors's Northwest Biotherapeutics, Inc. Common stock position peaked at $2.54M in Q2 2013.
80 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2015.

Based on Whitebox Advisors's 13F filing for Q4 2015, filed 10 Feb 2016.